Dinner symposium registration has closed.
Personalizing locoregional therapy in HR+/HER2- early breast cancer and emerging adjuvant strategies – What should we do in 2024 and beyond?
Saturday, 12 October 2024, 17:00 - 18:30 Hours
- Personalizing locoregional therapy in HR+/HER2- early breast cancer and emerging adjuvant strategies
- Optimizing management of different HR+/HER2- early breast cancer populations in adjuvant treatment